In PCa it is involved in beta-N-acetylgalactosaminylation of prostate-specific antigen (PSA) during prostate carcinogenesis, and it is a potential marker of unfavorable prognosis in lymph node-negative locally advanced PCa [26]. This evidence concerns the gene KLK3 and posterior cortical atrophy.